Biotechnology Market Share to Surge by 2034 with Strong Demand in AI-Powered and Data-Driven Bio-Technologies

According to a report by Straits Research, the global biotechnology market size is estimated at USD 1,650 billion in 2025 and is projected to reach USD 5,220 billion by 2034, growing at a CAGR of 13.67% during the forecast period.

Biotechnology today is no longer limited to pharmaceuticals alone it spans healthcare diagnostics and therapeutics, agriculture and food production, environmental and industrial bio-manufacturing, and bioinformatics. With the convergence of life sciences with digital technologies, big data analytics, and advanced manufacturing initiatives, biotechnology is reshaping global economies and opening vast new opportunities.

Explore the full report for trends, tables, and market analysis: https://straitsresearch.com/report/biotechnology-market

Market Overview:
The biotechnology market covers a wide breadth of technologies including nano-biotechnology, tissue engineering and regeneration, DNA sequencing, cell-based assays, fermentation, PCR technology, chromatography, and other advanced molecular tools.
Applications span human health (diagnostics, therapeutics, personalised medicine), food and agriculture (bio-fertilisers, GM crops), natural resources & environment (bio-remediation, bio-based materials), industrial processing, and bioinformatics.

North America currently leads the market, accounting for approximately 42.17% share in 2025. The Asia-Pacific region is forecast to grow at the fastest rate with a projected CAGR of 15.73% over the period.

Key Market Drivers:
1. Integration of Big Data Analytics & AI in Biotechnology
Biotechnology firms are increasingly leveraging big data analytics, machine-learning and AI-based drug discovery platforms to accelerate R&D. For example, the push towards AI-powered drug discovery is cited explicitly in the report as a key growth trend.

2. Strong Public-Private & Domestic Manufacturing Initiatives
Major governments are supporting biotechnology through funds and manufacturing initiatives such as the UK's Life Sciences Innovative Manufacturing Fund and Germany's High Tech Gründerfonds for early-stage innovations.

3. Broadening Demand Across Healthcare, Agriculture & Environment
The growing burden of chronic and rare diseases (driving precision medicine), the need for sustainable agriculture, and industrial bio-manufacturing (bio-based materials, circular economy) are all fueling biotechnology adoption worldwide.

Major Trends & Technology Insights:
The DNA sequencing segment dominated the technology category in 2025 with a 21.75% revenue share, driven by next-generation sequencing (NGS) expansion globally.

The bioinformatics application segment is expected to record the fastest CAGR (~14.35%) during the forecast period as data analysis becomes integral to biotechnology solutions.

A major trend is the shift from conventional PCR to digital PCR (dPCR) for enhanced precision and sensitivity in molecular diagnostics a development highlighted in the report.

Challenges & Restraints:
One key restraint facing the biotechnology market is the fragmented regulatory landscape across regions, which can delay commercialization of biologics and other advanced biotech products.
Inconsistent regulatory frameworks, varying approval requirements (e.g., INDs, BLAs in the U.S.), and differences in global market access weigh on global expansion for many biotech firms.

Request your free sample to see segment forecasts and key insights: https://straitsresearch.com/report/biotechnology-market/request-sample

Regional Insights:
North America: With the largest share (~42.17% in 2025), the region benefits from established biotech infrastructure, high R&D spending, and regulatory support such as the U.S. National Biotechnology Initiative Act (NBIA) which strengthens federal coordination in emerging biotech.

Asia-Pacific (APAC): The fastest-growing region with ~15.73% CAGR, driven by rapid technology adoption (DNA sequencing, synthetic biology), expanding healthcare infrastructure, and strong government initiatives in China, India, Japan and South Korea.

Europe: Growth is propelled by sustainability initiatives (e.g., EU Green Deal), white-biotechnology (bio-based materials, industrial enzymes) and large investments like BioNTech's UK expansion.

Latin America: Growth driven by agriculture biotech (GM crops, bio-fertilisers) and rising biologics sector adoption.

Middle East & Africa (MEA): Although currently smaller in share, the region is building bio-manufacturing capacity, genomics infrastructure and forming partnerships to address communicable and epidemic-prone diseases.

Segment Insights:
By Technology:
DNA sequencing holds the largest share (≈21.75% in 2025)
Nano-biotechnology is the fastest growing with projected CAGR ~15.2%

By Application:
Human health (diagnostics, therapeutics) remains the largest application segment (≈35.6% share in 2025)
Bioinformatics is expected to grow fastest due to its central role in biotechnology workflows.

Purchase the complete report for full data and recommendations: https://straitsresearch.com/buy-now/biotechnology-market

Competitive Landscape & Key Players:
The global biotechnology market is fragmented yet competitive, with major players driving innovation through strategic investments, partnerships and acquisitions. Leading companies include:

AstraZeneca
Gilead Sciences, Inc.
Bristol-Myers Squibb Company
Sanofi
Biogen
Abbott
Pfizer, Inc.
Amgen Inc.
Regeneron Pharmaceuticals, Inc.
Illumina, Inc.
Moderna, Inc.

For example: In August 2025, Ionis Pharmaceuticals secured U.S. FDA approval for Dawnzera (donidalorsen), the first RNA-targeted prophylactic treatment for hereditary angioedema. In March 2025, AstraZeneca committed USD 2.5 billion to establish a new R&D centre in Beijing with an AI and data science lab to advance biotech innovation.

Outlook & Conclusion:
The biotechnology market is entering a phase of robust expansion, driven by disruptive technologies, government support, and cross-sector adoption from healthcare to agriculture and environment. With forecasted revenues exceeding USD 5.22 trillion by 2034 and an anticipated CAGR of 13.67%, the industry holds immense opportunity for both established players and emerging innovators.

Companies looking to capitalise should emphasise:

Scaling digital and AI-driven biotech platforms
Forming public-private collaborations and leveraging manufacturing initiatives
Navigating regulatory complexities through global alignment
Targeting growth in fast-developing regions such as Asia-Pacific and Latin America

As biotechnology continues to converge with data science, engineering and environmental sustainability, stakeholders who adapt to this holistic transformation will drive the next generation of growth across global markets.

Contact Us :
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)
sales@straitsresearch.com

About Us :
Straits Research is a market intelligence company providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision-makers. Straits Research Pvt. Ltd. provides actionable market research data, especially designed and presented for decision making and ROI.

This release was published on openPR.